  | Fysekidis, M., Hadjadj, S., Roussel, R., Bellili, N., Madani, S., Fumeron, F., Leblanc, H., Gautier, J., Weekers, L., Bauduceau, B., Charpentier, G., Virally, M., Alhenc-Gelas, F., Lefèbvre, P., & Marre, M. (September 2007). ACE I/D polymorphism predicts end stage renal disease and or mortality in type I diabetic patients except for those with already advanced nephropathy: the follow up of the Genesis/Genediab Studies. Diabetologia, 50 (Suppl. 1), 157-S158.  Peer Reviewed verified by ORBi |